ArticleTargeted oncology2015

Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study.

Irene Brana et al.PubMed ↗Publisher ↗

No numbers read from the abstract.